WO2023247664 - LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS
National phase entry:
Publication Number
WO/2023/247664
Publication Date
28.12.2023
International Application No.
PCT/EP2023/066896
International Filing Date
22.06.2023
Title **
[English]
LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS
[French]
VARIANTS DE LIPASE ET COMPOSITIONS COMPRENANT DE TELS VARIANTS DE LIPASE
Applicants **
NOVOZYMES A/S
Inventors
VIND, Jesper
Priority Data
22180938.7
24.06.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3415 | |
| EPO | Filing, Examination, Granting | 13600 | |
| Japan | Filing, Examination, Granting | 2213 | |
| South Korea | Filing, Examination, Granting | 2103 | |
| USA | Filing, Examination, Granting | 9690 |
Total:
31,021
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to lipase variants with reduced activity at pHs around neutral compared to the parent. The present invention also relates to compositions comprising a lipase variant of the invention; polynucleotides encoding lipase variants of the invention; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants for cleaning.[French]
La présente invention concerne des variants de lipase ayant une activité réduite à des pH plus ou moins neutre par rapport au parent. La présente invention concerne également des compositions comprenant un variant de lipase de l'invention ; des polynucléotides codant pour des variants de lipase de l'invention ; des constructions d'acide nucléique, des vecteurs et des cellules hôtes comprenant les polynucléotides ; et des procédés de production et d'utilisation des variants pour le nettoyage.